BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4629559)

  • 21. Analysis of the fibrin-polymerizing reaction using sodium dodecylsulfate-agarose gel electrophoresis.
    Moroi M; Inoue N; Yamasaki M
    Biochim Biophys Acta; 1975 Jan; 379(1):217-26. PubMed ID: 1168501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-linking of salmon fibrinogen and fibrin by factor XIII and transglutaminase.
    Murtaugh PA; Halver JE; Gladner JA
    Biochem Biophys Res Commun; 1973 Oct; 54(3):849-55. PubMed ID: 4148128
    [No Abstract]   [Full Text] [Related]  

  • 23. Subunit structure of the plasmin-induced degradation products of crosslinked fibrin.
    Gaffney PJ; Brasher M
    Biochim Biophys Acta; 1973 Jan; 295(1):308-13. PubMed ID: 4265363
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibrin cross-linking in congenital factor XIII deficiency.
    Rodeghiero F; Barbui T
    J Clin Pathol; 1980 May; 33(5):434-7. PubMed ID: 7400341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition.
    Glover CJ; McIntire LV; Brown CH; Natelson EA
    J Lab Clin Med; 1975 Oct; 86(4):644-56. PubMed ID: 1176815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
    Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
    Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human mononuclear phagocyte transglutaminase activity cross-links fibrin.
    Conkling PR; Achyuthan KE; Greenberg CS; Newcomb TF; Weinberg JB
    Thromb Res; 1989 Jul; 55(1):57-68. PubMed ID: 2571199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor).
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Biol Chem; 1971 Sep; 246(18):5851-4. PubMed ID: 5096097
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma and platelet fibrinogen differ in gamma chain content.
    Francis CW; Nachman RL; Marder VJ
    Thromb Haemost; 1984 Feb; 51(1):84-8. PubMed ID: 6719392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of factor XIII by SDS polyacrylamide gel electrophoresis.
    Godal HC; Gravem K; Brosstad F; Nyvold N
    Thromb Res; 1984 Sep; 35(5):577-82. PubMed ID: 6484899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.
    Francis CW; Connaghan DG; Scott WL; Marder VJ
    Circulation; 1987 Jun; 75(6):1170-7. PubMed ID: 3568326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Our ancient heritage in blood clotting and some of its consequences.
    Laki K
    Ann N Y Acad Sci; 1972 Dec; 202():297-307. PubMed ID: 4508929
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrinogen of relatively high solubility, III. Residual clottable material in plasma deprived of the majority of fibrinogen.
    Jilg W; Hörmann H
    Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1316-24. PubMed ID: 4461634
    [No Abstract]   [Full Text] [Related]  

  • 34. Carboxyl-terminal structures of mammalian fibrinogen and fibrin.
    Iwanaga S; Okude M
    Ann N Y Acad Sci; 1972 Dec; 202():308-17. PubMed ID: 4508930
    [No Abstract]   [Full Text] [Related]  

  • 35. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative studies on tissue transglutaminase and factor XIII.
    Chung SI
    Ann N Y Acad Sci; 1972 Dec; 202():240-55. PubMed ID: 4629552
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelet and plasma fibrinogens are identical gene products.
    Doolittle RF; Takagi T; Cottrell BA
    Science; 1974 Jul; 185(4148):368-70. PubMed ID: 4834369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinoligase: the fibrin-stabilizing factor system of blood plasma.
    Lorand L
    Ann N Y Acad Sci; 1972 Dec; 202():6-30. PubMed ID: 4565370
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis and classification of factor XIII deficiencies.
    Kohler HP; Ichinose A; Seitz R; Ariens RA; Muszbek L;
    J Thromb Haemost; 2011 Jul; 9(7):1404-6. PubMed ID: 22946956
    [No Abstract]   [Full Text] [Related]  

  • 40. [Proceedings: Determination of Factor XIII (fibrin-stabilizing factor) in plasma and blood platelets].
    Ballerini G; Franceschini F; Guerra S; Meduri P; Scagliarini F
    Quad Sclavo Diagn; 1973 Mar; 9(1):497-581. PubMed ID: 4210088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.